Airbus Steady as Analysts See 20% Upside

Airbus heads into the final stretch of October with a story that is less about short-seller pressure and more about whether the stock can close the gap between its current price and what analysts think it is worth.

The most striking tension this week is valuation. Airbus trades at EUR 192.74, roughly flat on the month but down a third of a percent on the day. The mean analyst price target is EUR 230.52, implying around 20% upside from here. That gap is wide enough to be interesting, particularly for a EUR 170 billion company with a short score of just 27.8, placing it in the low-risk segment of the ORTEX universe. The PE ratio has eased to 22.8 over the past 30 days, a modest compression that makes the valuation picture slightly less demanding than it was. EV/EBITDA has also drifted lower, to 12.1, suggesting multiples are gradually moving in the bulls' favour even as the share price marks time.

The lending market offers almost no tension. Availability has climbed sharply over the past week to 4,703%, meaning lenders hold roughly 47 shares for every one already borrowed. That is well above even the 52-week low availability reading of 2,856%, which was itself loose territory. Cost to borrow has fallen nearly 30% on the week to 0.72%, and the ORTEX short score of 27.8 ranks in the 82nd percentile for low short pressure. Short interest as a fraction of the free float is negligible. There is no squeeze dynamic here, no borrow squeeze, no building of short conviction and nothing in the lending market to complicate the bull case.

What bulls and bears are debating is almost entirely operational. The ORTEX factor scores show a dividend rank of 85, reflecting Airbus's history of steady payouts, but the forward earnings growth score is weak at 22, near the bottom of the range. EPS surprise ranks a more respectable 69, meaning the company has tended to beat estimates, but the 12-month forward year-on-year earnings growth trajectory raises questions about how much upside is left in the profit cycle. The quality of the balance sheet is not in doubt; what is contested is whether the production ramp, which the company has been working through across its narrowbody programme, translates into earnings growth that justifies the premium the Street is pricing in.

Among closest correlated peers, SAF fell 12.2% on the week, a sharp move that stands out against Airbus's relative calm. Safran's decline likely reflects sector-specific supply chain noise rather than a clean read-through to Airbus, but the contrast is worth watching. Thales and Aero each held or gained slightly, while MTX slipped around 5%. Airbus's modest weekly decline of 0.4% looks composed against that backdrop.

The next scheduled earnings event is February 2027, leaving several months of operational newsflow before the market gets a fresh read on delivery cadence and margin progress. With Q3 results landing on October 28, today's print will be the immediate focus. Whether delivery volumes and free cash flow guidance are sufficient to justify the analyst consensus will determine whether the EUR 230 price target remains a reasonable destination or starts to look optimistic.